Pharmaceutical Technology

JULY 29, 2022

Pfizer (New York, New York) and Moderna’s (Cambridge, Massachusetts) Omicron-specific Covid-19 vaccines are in late-stage development, have demonstrated good efficacy against the variant and will likely be available to the public later this year to provide an additional booster and increase demand for injectable manufacturing.

Manufacturing 130

Manufacturing Vaccination Vaccine Packaging 130

Pharmaceutical Technology

MAY 8, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Antibody 147

Antibody Vaccination Vaccine Dermatology 147

Pharmaceutical Technology

MAY 2, 2023

IO agents include the classes of immune checkpoint modulators, cell therapies, bispecific antibodies, oncolytic viruses, therapeutic vaccines, and cytokines. Oncolytic viruses, cytokines, and therapeutic vaccines currently play a very minimal role in oncology treatment, with substantial efficacy still to be demonstrated for these classes.

Genetic Engineering 130

Genetic Engineering Antibody Clinical Trials Clinical Trials 130

Pharmaceutical Technology

JULY 14, 2022

This analysis is based on the GlobalData Pharma Intelligence Center’s Deals database and PharmSource reports. Covid-19 vaccines stay in the spotlight. Even as regulatory agencies contemplate the authorization of Omicron-specific Covid-19 vaccines , existing versions continue to make headlines.

Manufacturing 130

Manufacturing Drugs Vaccination Vaccine 130

Pharmaceutical Technology

MARCH 9, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Protein 130

Protein Antibody DNA Research 130

Pharmaceutical Technology

JUNE 23, 2022

The global healthcare and pharmaceutical industry is frequently faced with having to find new ways of innovating and carrying out its work in order to overcome tragic circumstances that will typically come with a huge human cost. In 2021,18% of all trials adopted a decentralised component, according to research by GlobalData.

Trials 130

Trials Clinical Trials Clinical Trials Drug Delivery 130

Pharmaceutical Technology

NOVEMBER 23, 2022

Since the onset of the pandemic, the government has invested more than C$1.2bn in 28 Covid-19 domestic biomanufacturing, vaccine and therapeutics projects. OmniaBio, a contract development and manufacturing organization (CDMO) focused on cell and gene therapies, is one of the companies moving into MIP, having broken ground in October.

Marketing 130

Marketing Gene Therapy Life Science Manufacturing 130

XTalks

MAY 2, 2024

Moderna’s RSV Vaccine Maker: Moderna PDUFA: May 12, 2024 Estimated 2028 revenue: $913 million After GSK won the first ever FDA approval for an RSV vaccine with Arexvy , closely followed by approval of Pfizer’s RSV shot Abrysvo last year, Moderna isn’t too far behind with its RSV vaccine. At the J.P. percent to 77.8

Drugs 52

Drugs FDA Approval Sales Vaccination 52

Pharmaceutical Technology

NOVEMBER 9, 2022

According to a recent GlobalData report, healthcare professionals have – for the second year in a row – ranked artificial intelligence (AI) and Big Data as the top two technologies revolutionising the pharmaceutical sector. Digital transformation is permeating the entire pharmaceutical supply chain. what it means for you.

Big Data 130

Big Data Manufacturing Packaging Packaging 130

Pharmaceutical Technology

FEBRUARY 1, 2023

As paediatric hospital wings are flooded with an unprecedented number of respiratory syncytial virus (RSV) cases , healthcare workers have been overwhelmed by an unusually early peak of the RSV season. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccination 162

Vaccination Vaccine Antibody FDA Approval 162

pharmaphorum

NOVEMBER 19, 2021

The race to find and bring vaccines to market to fight Covid was impressive. It’s been almost a year since the first Covid vaccine was authorised for use. The mRNA jab, developed by Pfizer and BioNTech, launched to huge fanfare in December 2020 and promised the start of the end of the coronavirus pandemic.

Sales 137

Sales Vaccination Vaccine Marketing 137

Pharmaceutical Technology

DECEMBER 27, 2022

Once lockdown measures eased and Covid-19 vaccines and boosters became available, the industry anticipated a significant recovery in the market and in the number of deals. billion acquisition of Global Blood Therapeutics (GBT), a life sciences company that develops treatments for several blood disorders including sickle cell disease.

Life Science 130

Life Science Marketing Manufacturing Contract Manufacturing 130

Pharmaceutical Technology

JUNE 4, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Gene 262

Gene Gene Therapy Genetics DNA 262

Pharmaceutical Technology

SEPTEMBER 26, 2022

The company told GlobalData PharmSource: “The biosimilar facilities in Austria and Slovenia would continue to manufacture biosimilars for Sandoz under a contractual agreement with Novartis. These highlight the parent company’s focus on innovative and high-value drug development.

Manufacturing 162

Manufacturing Drugs Branding Sales 162

Pharmaceutical Technology

FEBRUARY 15, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

DNA 130

DNA Antibody Vaccination Vaccine 130

pharmaphorum

SEPTEMBER 16, 2022

The former blockbuster – first approved back in 1998 – is still making solid sales despite losing patent protection, with AZ booking $410 million from the drug last year, but are expected to drop sharply once Beyfortus and vaccines for RSV prevention reach the market. Both vaccines are also being tested in older adults.

Antibody 59

Antibody Vaccination Vaccine Marketing 59

Pharmaceutical Technology

APRIL 24, 2023

Demand for biologics, including vaccines, is at an all-time high, in the post-Covid era. Having steadily risen over the last two decades, 2020 saw more approvals for biopharmaceuticals, often termed as biologics, than any other year in the last decade, according to GlobalData analysis.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Protein Sales 130

Pharmaceutical Technology

MARCH 20, 2023

Source: GlobalData. In the fourth quarter of 2022, the most recent period for which data is available, GlobalData estimates suggest the value of venture capital investment in pharmaceutical firms worldwide was $7.8 The mRNA technology that enabled the largest and fastest vaccine rollout in history is the tip of the innovation iceberg.

Gene Therapy 225

Gene Therapy Genome Genomics Gene 225

Pharmaceutical Technology

APRIL 12, 2023

The Association of the British Pharmaceutical Industry (ABPI) also states that “the use of animals in medical research has played and continues to play an essential role in the development of new medicines and vaccines”. The topic of animal testing remains a fiercely contentious topic in the public eye.

Regulation 245

Regulation Vaccination Vaccine Medicine 245

Pharmaceutical Technology

MARCH 29, 2023

Pharmaron is receiving a £151 million investment in capital to support the growth of operations in Liverpool, quadrupling production capacity for gene therapy and vaccine components. The government is giving Touchlight £14 million for commercial scale manufacturing of its “doggybone DNA” vector at its Hampton, London base.

Life Science 276

Life Science Manufacturing Gene Therapy Medicine 276

Pharmaceutical Technology

MARCH 21, 2023

In this month’s edition, which covers events from late January to early March, manufacturing contract-related data from GlobalData’s PharmSource reports and news from GlobalData’s Pharma Intelligence Center have been collated to identify stakeholders at the center of new developments.

Manufacturing 147

Manufacturing Drugs Packaging Packaging 147

Pharmaceutical Technology

JANUARY 5, 2023

The swift development of COVID-19 vaccines was an unprecedented scientific and collaborative achievement by government, regulators, research institutions, and the pharmaceutical industry. The outlook for global growth continues to deteriorate as inflation continues to significantly exceed the target of 2% in most developed markets.

Drugs 173

Drugs Regulation Marketing Vaccination 173

Pharmaceutical Technology

FEBRUARY 20, 2023

This may sound obvious, but it is still a major hurdle in drug development. A 2022 report published by GlobalData found that in analysis of 12,698 clinical trials initiated over nine and a half years to June 2022 racial minority representation in pivotal studies is extremely low, accounting for 23.9%

Research 130

Research Clinical Trials Clinical Trials Trials 130

Pharmaceutical Technology

MAY 9, 2023

According to GlobalData analysis, the number of clinical trials with a decentralised and virtual component increased by 50% between 2020 and 2021, and this trend is here to stay. GlobalData analysis shows that Asia-Pacific is one of the fastest-growing geographies for clinical research, accounting for more than 50% of global trials in 2022.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Big Data 130

Pharmaceutical Technology

JANUARY 25, 2023

Uptake of mobile healthcare, wearable devices and web-based technologies meant decentralised clinical trials made up 30% of overall trials in 2021 – an increase of 9% since 2015. Sea change Findings from GlobalData point to rising interest in trial decentralisation across the pharmaceutical industry.

Clinical Trials 147

Clinical Trials Clinical Trials Trials Research 147

Pharmaceutical Technology

JANUARY 25, 2023

Uptake of mobile healthcare, wearable devices and web-based technologies meant decentralised clinical trials made up 30% of overall trials in 2021 – an increase of 9% since 2015. Sea change Findings from GlobalData point to rising interest in trial decentralisation across the pharmaceutical industry.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130